Thoracic Malignancy, Lung cancer, lung tumor, Lung carcinoma, SCLC (small cell lung cancer), NSCLC (non-small cell lung cancer), Adenocarcinoma, Squamous cell carcinoma, Large cell carcinoma, Thymus cancer, Mesothelioma
Conditions
Interventions
None listed
Sponsors
Stichting NVALT-studies
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Age = 18 years;Histo/cytopathological proof of a thoracic malignancy, or a strong suspicion (after imaging and multidisciplinary board);Informed consent for longitudinal observational data collection;
Exclusion criteria
Exclusion criteria: Mentally challenged patients that are unable to provide conscientious informed consent as determined by the investigator.Inability to provide a written or electronic informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical parameters as comprehensive as possible: medical history, co-morbidities, medication use, basic physical examination, laboratory results, imaging results, pathology results, tumor characteristics, treatment, treatment outcomes, hospital stays, interventions, pharmaco-economic data and adverse events. Clinical endpoints: overall survival and if available treatment response, disease-free survival, progression-free survival, overall survival and grade 3/4 (serious) adverse events. Follow up treatments in case of progressive or recurrent disease. Patient reported outcomes: health related quality of life, work participation and work ability. Biobanking of blood and (tumor) tissue and storage of imaging. | — |
Countries
Netherlands
Contacts
Public ContactW.K. Jong
Universitair Medisch Centrum Utrecht
Outcome results
None listed